CRSwNP, with a prevalence of 2–4% in western countries, is a predominantly type 2 inflammation leading to IgE antibody production and recruitment and activation of eosinophils, considered a pathological landmark of CRSwNP [14]. This evidence concerns the gene IGHE and chronic rhinosinusitis with nasal polyps.